http://www.unboundmedicine.com/medline/ebm/research/alefaceptUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19919807/full_citation/Cost_Comparison_of_Psoriasis_Treatments_Mikhael D, Babcock K, Desgroseilliers JP 
Cost Comparison of Psoriasis Treatments. [JOURNAL ARTICLE]
J Cutan Med Surg 2009 Dec 1; 13(6):303-307.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917955/full_citation/Alefacept_for_severe_alopecia_areata:_a_randomized_double_blind_placebo_controlled_study_Strober BE, Menon K, McMichael A, et al. 
Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study. [Journal Article, Research Support, Non-U.S. Gov't]
Arch Dermatol 2009 Nov; 145(11):1262-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916298/full_citation/The_status_of_biologic_therapies_in_the_treatment_of_moderate_to_severe_psoriasis_Menter A 
The status of biologic therapies in the treatment of moderate to severe psoriasis. [Journal Article, Research Support, Non-U.S. Gov't]
Cutis 2009 Oct; 84(4 Suppl):14-24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845720/full_citation/Long_term_efficacy_of_biologics_in_the_treatment_of_psoriasis:_what_do_we_really_knowAlwawi EA, Krulig E, Gordon KB 
Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? [Journal Article]
Dermatol Ther 2009 Sep-Oct; 22(5):431-40.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845719/full_citation/Is_there_truly_a_risk_of_lymphoma_from_biologic_therapiesDommasch E, Gelfand JM 
Is there truly a risk of lymphoma from biologic therapies? [Journal Article]
Dermatol Ther 2009 Sep-Oct; 22(5):418-30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19807998/full_citation/A_mechanism_based_classification_of_dermatologic_reactions_to_biologic_agents_used_in_the_treatment_of_cutaneous_disease:_Part_2_Bremmer M, Deng A, Gaspari AA 
A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 2. [Journal Article]
Dermatitis 2009 Oct; 20(5):243-56.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19804694/full_citation/A_mechanism_based_classification_of_dermatologic_reactions_to_biologic_agents_used_in_the_treatment_of_cutaneous_disease:_Part_1_Bremmer M, Deng A, Gaspari AA 
A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. [Journal Article]
Dermatitis 2009 Aug; 20(4):182-92.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19742267/full_citation/Biological_agents_targeting_beyond_TNF_alpha_Sharma R, Sharma CL, Mahajan A 
Biological agents targeting beyond TNF-alpha. [Journal Article]
Indian J Crit Care Med 2008 Oct; 12(4):181-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19712190/full_citation/European_S3_Guidelines_on_the_systemic_treatment_of_psoriasis_vulgaris_Pathirana D, Ormerod A, Saiag P, et al. 
European S3-Guidelines on the systemic treatment of psoriasis vulgaris. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Oct; 23(s2):1-70.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19708743/full_citation/Are_isomers_of_the_vinyl_cyanide_ion_missing_links_for_interstellar_pyrimidine_formationBera PP, Lee TJ, Schaefer HF 
Are isomers of the vinyl cyanide ion missing links for interstellar pyrimidine formation? [Journal Article]
J Chem Phys 2009 Aug 21; 131(7):074303.
Abstract | Full Citation | Find Related Articles